FINWIRES · TerminalLIVE
FINWIRES

Apeloa Pharmaceutical's Unit Gets EU Certificate for Amantadine Hydrochloride

By

Apeloa Pharmaceutical's (SHE:000739) unit, Zhejiang Apeloa Kangyu Pharmaceutical, received a certificate of suitability from the European Union for its amantadine hydrochloride, according to a Shenzhen bourse filing on Friday.

The drug is used to treat symptoms caused by influenza A virus infection, as well as Parkinson's Disease.

Related Articles